InsiderClue
Insiders · Profile

SNODGRASS H. RALPH

PRES./CHIEF SCIENTIFIC OFFICER at Vistagen Therapeutics. Filing since 20 Nov 2019. CIK 0001415876

Company
Date
Role
Action
Shares
Amount
Of holding
VTGN Vistagen Therapeutics, Inc.
17 Aug 2021
PRES./CHIEF SCIENTIFIC OFFICER
Bought
3,750
$10.24K
12.1%
VTGN Vistagen Therapeutics, Inc.
20 Nov 2019
PRES./CHIEF SCIENTIFIC OFFICER
Bought
15,000
$5.10K
opened
2 decisions on file.